Cipla Medpro: R345m state asthma tender won

Comment on this story

The government had awarded Cipla Medpro a R345 million share in the national respiratory tender as South Africa sought to cut high asthma mortality rates, the company said yesterday. “In South Africa, asthma is the third most common cause of hospital admissions of children, yet only 2 percent receive treatment,” the chief executive, Paul Miller, said. South Africa has the world’s fourth highest asthma death rate among people aged five to 35, with thousands dying each year from a disease that causes shortness of breath, wheezing and coughing, according to the Global Initiative for Asthma. Under the contract, which starts on July 1 and runs to April 30, 2017, the third-largest local drug maker will provide asthma medication to state facilities. – Reuters

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines